Sort by
Refine Your Search
-
for the project Pre-application research of drugs for oncological diseases and for the prevention and treatment of serious complications caused by them (OncoPharm), project ID CZ.02.01.01/00/23_021/0008442, within
-
). Introduction and application of in vitro methods for testing pharmacokinetic drug interactions. Work with in vitro cell cultures and recombinant enzymes. Isolation and work with ex vivo primary cultures obtained
-
a variety of health care settings (primarily in acute and outpatient care), has significant practical clinical experience related to clinical individualization of drug treatment in geriatric patients
-
execution of experiments for VZ2 (WP2). Introduction and application of in vitro methods for the study of cardiotoxicity of anticancer drugs with a focus on the role of topoisomerase II and the development
-
). Introduction and application of in vitro methods for testing pharmacokinetic drug interactions. Work with in vitro cell cultures and recombinant enzymes. Isolation and work with ex vivo primary cultures obtained
-
conditions with a focus on cardiometabolic diseases, Protein and gene analysis of selected groups of proteins/genes potentially affected by pathological conditions and drugs, their processing and
-
supplements and food. Previous experience in analytical chemistry (LC-MS, especially LC-HRMS and advanced statistical data analysis) and drug metabolism is an advantage. Education and PhD in a science related
-
on the content of the work: doc. PharmDr. Petra Štěrbová, Ph.D. – Department of Pharmaceutical Chemistry and Drug Analysis Phone: +420 495 067 236 e-mail:[email protected] The project New Technologies